MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinsonism"

  • 2019 International Congress

    Does Anticholinergic Burden Affect the Outcomes in Patients Diagnosed with Parkinson’s Disease?

    S. Taylor, E. Jones (York, United Kingdom)

    Objective: To explore the impact of an anticholinergic burden on various outcomes in Parkinson’s disease. Background: Over 600 different medications possess some anticholinergic effect.[1] There…
  • 2019 International Congress

    APOmorphine infusion and aMYLoid deposition in Parkinson’s disease (APOMYL): preliminary clinical and amyloid imaging data

    D. van Wamelen, M. Politis, D. Aarsland, P. Odin, T. van Laar, T. Henriksen, B. Corcoran, G. Vivian, H. Wilson, M. Parry, A. Sauerbier, N. Mulholland, K. Chaudhuri (London, United Kingdom)

    Objective: To explore the potential effects of chronic Apomorphine infusion treatment on reducing brain Amyloid-b (Aβ) deposition in Parkinson’s disease (PD). Background: A majority of…
  • 2019 International Congress

    The relationship between constipation and alteration of gut microbiota in patients with Parkinson’s disease

    BI. Zao An, M. Ye (Nanjing, China)

    Objective: To  study compositional and functional differences  in the gut microbiota  and its products between  individuals with PD and matched controls,and these differences  are  or…
  • 2019 International Congress

    Initial Validation of the Cortical Basal ganglia Functional Scale (CBFS) in two international, multicenter cohorts: 4RTNI and PROSPECT

    A. Boxer, P. Wang, H. Morris, G. Stebbins, A. Lang (Toronto, ON, Canada)

    Objective: To assess the validity of a patient/caregiver-reported scale for assessing functional disability in 4R tauopathies. Background: 4R tauopathies (4RT) including progressive supranuclear palsy (PSP),…
  • 2019 International Congress

    Serotonergic function in De Novo Parkinson’s Disease

    HK. Park, JJ. Lee, YM. Park (Goyang, Republic of Korea)

    Objective: We aimed to investigate the central serotonergic function in de novo PD and change in serotonergic function with dopaminergic medications. Background: While dopaminergic dysfunction…
  • 2019 International Congress

    Carpal Tunnel Syndrome in Patients with Tremor

    L. Jackson, F. Ali (Rochester, MN, USA)

    Objective: To determine whether patients who present with tremor have an increased risk of carpal tunnel syndrome (CTS). Background: Carpal tunnel syndrome is the most…
  • 2019 International Congress

    A new screening tool to detect psychoaffective states in patients with Parkinson´s disease

    C. Schedlich-Teufer, M. Sommerauer, S. Jost, S. Schnitzler, H. Dafsari, E. Kalbe, J. Kessler, M. Barbe (Cologne, Germany)

    Objective: To develop a novel screening tool by pooling items from international self-assessment scales detecting psychoaffactive states such as mania, apathy, anxiety, depression and impulse…
  • 2019 International Congress

    IMPACT OF PAIN ON STROKE AND HYPERTENSION AS COMORBIDITIES IN PARKINSON’S DISEASE

    V. Wijaya, R. Pinzon, A. Al Jody (Yogyakarta, Indonesia)

    Objective: This study aimed to report the prevalence and type of pain in patients with PD, and to determine the relationship between each type of…
  • 2019 International Congress

    Procedural Memory Changes of Parkinson’s Disease Patients Post Participation in Boxing

    A. Ghaffar, R. Gallagher, C. Mcleod, A. Leder (Old Westbury, NY, USA)

    Objective: Can participation in a Rock Study Boxing program improve procedural memory in people with Parkinson’s disease (PD)? Background: Procedural memory is important for daily…
  • 2019 International Congress

    Relationship between cognitive performance and mobility in patients with Parkinson´s disease: A cross-sectional study

    N. Sousa, R. Macedo, S. Brucki (Salvador, Brazil)

    Objective: To investigate the relationships between cognitive ability (global and single domain-executive functions) and gait performance (balance, gait speed and mobility) in patients with Parkinson's…
  • « Previous Page
  • 1
  • …
  • 211
  • 212
  • 213
  • 214
  • 215
  • …
  • 405
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • #24970 (not found)
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Effect of marijuana on Essential Tremor: A case report
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley